Danilov, A. V., Li, H., Shadman, M., Rimsza, L., Zebari, A., Smith, S. M., . . . Song, J. Y. (2025). Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationDanilov, Alexey V., et al. Minimal Residual Disease Status Predicts Outcomes in Patients with Follicular Lymphoma Treated with Chemo-immunotherapy on the SWOG S0016 Trial. Ferrata Storti Foundation, 2025.
MLA (9th ed.) CitationDanilov, Alexey V., et al. Minimal Residual Disease Status Predicts Outcomes in Patients with Follicular Lymphoma Treated with Chemo-immunotherapy on the SWOG S0016 Trial. Ferrata Storti Foundation, 2025.
Warning: These citations may not always be 100% accurate.